Clinical trial
A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus…
NCT00236795 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Completed
Key facts
| NCT number | NCT00236795 |
|---|---|
| Title | A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Triphasil. |
| Official title | An Open-label Study to Evaluate the Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of 17-deacetylnorgestimate and Ethinyl Estradiol With the Oral Contraceptive Triphasil. |
| Lead sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Contraception, Female Contraception |
| Intervention type | Drug |
| Interventions | norelgestromin + ethinyl estradiol, triphasil. |
| Enrollment | 1,494 |
| Start date | Jan 1, 1997 |
| Completion | Mar 1, 1999 |
| First posted | Oct 12, 2005 |
| Last update posted | Jun 8, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: